Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL713550

CC(C)Oc1ccc(OCCN2CCOCC2)cc1-c1nc2cccnc2[nH]1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RUNX1 Q01196 3/20 0.46
APAF1 O14727 1/20 0.42
MITF O75030 1/20 0.42
CASP7 P55210 1/20 0.42
CASP9 P55211 1/20 0.42
CASP6 P55212 1/20 0.42
CASP8 Q14790 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CHUK O15111 3/20 0.42
INSR P06213 3/20 0.42
MAPK8 P45983 3/20 0.42
CAMKK2 Q96RR4 3/20 0.42
PPARG P37231 3/20 0.42
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
FGFR1 P11362 1/20 0.41
SRC P12931 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10206655 0.92 RUNX1 (0.46) RUNX1CHUKINSRMAPK8CAMKK2
Trifluoroacetic Acid SCHEMBL712076 0.86 RUNX1 (0.43) RUNX1APAF1MITFCASP7CASP9
Trifluoroacetic Acid SCHEMBL711170 0.82 FFAR1 (0.39) HPGDPDGFRBPDGFRA
Trifluoroacetic Acid SCHEMBL711385 0.82 CYP3A4 (0.39) KDM4EALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL708957 0.80 MAOB (0.36) PPARG
Trifluoroacetic Acid SCHEMBL711107 0.80 GPR132 (0.43) PPARG
Trifluoroacetic Acid SCHEMBL712435 0.79 SMO (0.40) PPARGKDM4E
Trifluoroacetic Acid SCHEMBL710536 0.79 HTT (0.46) L3MBTL1KDM4ENPC1ALDH1A1ACHE
Trifluoroacetic Acid SCHEMBL710679 0.79 ACHE (0.44) ADORA2AADORA1ACHE
SCHEMBL10206661 0.77 ACHE (0.49) RUNX1ADORA2AADORA1SRCKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK RUNX1 3313/4885APAF1 3224/4885MITF 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.